Genmab — Januar 2019

[Bulder]

So far, the agency’s sizable coffer of leftover cash has ensured that the FDA can continue to review any drug applications submitted before the shutdown began. Janssen har formentlig indsendt de første data i november - hvis der kører RTOR.

[AaBforever]

Man kan vel opsummere at den får klø i øjeblikket.

[E_L]

yes, i hope so @Bulder

[AaBforever]

Vi kunne godt trænge til nye positive nyheder.

[AaBforever]

Nu er spørgsmålet om medicinpriser i USA kommet til overfladen igen. Måske det også har indflydelse.

[Vitus]

Novo ligger da fint i plus......

[Vitus]

Og det kommer Genmab jo nok også i dag..

[AaBforever]

Novo faldt i går.

[Legolas23]

God betragtning @Bulder.

[E_L]

I have not been able to find yet if Dara had a price hike last week; anybody else maybe?

[Nickstar]

Vitus, mønstret igennem 1,5 år ca er det samme i mine øjne,....køres lidt op for så at falde tilbage igen

[Solsen]

As I recall 3-4% price hike

[Solsen]

Mon ikke vi er i 10-11 uger inde i RTOR processen

[Solsen]

I read an article about the price hike where it was mentioned tha
t end user prices didnt raise.

[E_L]

yea, that was probably the one Bulder posted last week https://www.reuters.com/article/us-johnson-johnson-drugpricing/jj-raises-u-s-prices-on-around-two-dozen-drugs-idUSKCN1P42VY?il=0 , it does not specify if Dara is included though

[bibob]

Mener disse priser er fra okt 18 i US. https://www.drugs.com/price-guide/darzalex

[bibob]

Siden findes ikke

(borsen.dk)

[Helge_LarsenPI-redaktør]

Hans Henriks nye video med Genmab: http://www.proinvestor.com/debat/76625

[E_L]

where do you see this is from okt 18 @bibob ?

[bibob]

E L. Here is it from JnJ. Sep update.18. I Saw it another place, but can`t find it Again. But i was okt 18 https://www.janssencarepath.com/patient/darzalex/cost-support